Search

everythinglearnresearchcommunity

for

Search:↓

Researchers created a fully functional, bioengineered skin system with hair from stem cells that successfully integrated when transplanted into mice.

Some alternative treatments for hair loss might work, but more research is needed.

Cedrol Nanoemulsion was found to be more effective at promoting hair growth than traditional treatments and had better bioavailability.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

High levels of Demodex mites can cause eye and skin problems.

Certain bacteria may influence alopecia areata risk, but skin bacteria don't mediate gut-skin effects.

A mutation in the IL2RA gene increases the risk of alopecia areata.

Kids with alopecia areata had lower vitamin D levels than healthy kids.

Two people had unusual ring-shaped hair loss due to an autoimmune disorder.

Brevilin-A is a safe and effective treatment for mild to moderate alopecia areata in children.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

A new image-based method improves accuracy in measuring hair loss in mice.

A new image-based method improves accuracy in measuring hair loss in mice.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

A new microneedle patch effectively and safely treats alopecia areata.

Methylprednisolone infusions can help some people with severe alopecia regrow hair.

Nanocrystals improve alopecia areata treatment by better targeting hair follicles.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Granulomatous Alopecia Areata is rare and may be caused by hair antigens or follicle destruction.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Hair follicle size and distribution vary significantly across different body sites.

Alopecia areata affects 1.45% of people in Japan, impacting mood and self-esteem, with many not seeking treatment.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

The skin protects the body, regulates temperature, senses touch, and makes vitamin D.

PRP treatment may help with alopecia areata, especially in newer cases.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.